Relationship and significance between anti-b2-glycoproteinⅠantibodies and platelet activation state in patients with ulcerative colitis

被引:1
作者
Yan-Hang Gao
机构
基金
中国国家自然科学基金;
关键词
b2-glycoproteinⅠ; Anti-b2-glycoprotein; Ⅰ; antibodies; Ulcerative colitis; Platelet activation; Hypercoagulation;
D O I
暂无
中图分类号
R574.62 [结肠疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM:To study the relationship between anti-b2-glycoprotein Ⅰ (ab2GPⅠ) antibodies and platelet activation state in patients with ulcerative colitis (UC) and its significance. METHODS:Peripheral blood samples were collected from 56 UC patients (34 males and 22 females, aged 43.5 years, range 21-66 years), including 36 at active stage and 20 at remission stage, and 25 sex-and age-matched controls. The level of ab2GPⅠ was measured by ELISA. The platelet activation markers, platelet activation complex-Ⅰ (PAC-Ⅰ) and P-selectin (CD62P) were detected by flow cytometry. RESULTS:The A value for IgG ab2GPⅠ in the active UC group was 0.61 ± 0.13, significantly higher than that in the remittent UC and control groups (0.50 ± 0.13 and 0.22 ± 0.14, P < 0.01). There was a significant difference between the two groups (P < 0.01). The A value for IgM ab2GPⅠ in the active and remittent UC groups was 0.43 ± 0.13 and 0.38 ± 0.12, significantly higher than that in the control group (0.20 ± 0.12, P < 0.01). However, there was no significant difference between the two groups (P > 0.05). The PAC-Ⅰ positive rate for the active and remittent UC groups was 30.6% ± 7.6% and 19.6% ± 7.8% respectively, significantly higher than that for the control group (6.3% ± 1.7%, P < 0.01). There was a significant difference between the two groups (P < 0.01). The CD62P positive rate for the active and remittent UC groups was 45.0% ± 8.8% and 31.9% ± 7.8% respectively, significantly higher than that for the control group (9.2% ± 2.7%, P < 0.01). There was a significant difference between the two groups (P < 0.01). In the active UC group, the more severe the state of illness was, the higher the A value for IgG ab2GPⅠ was, and the positive rate for PAC-I and CD62P was positively correlated with the state of illness (Fab2GPⅠ = 3.679, P < 0.05;FPAC-I (%) = 5.346, P < 0.01;and FCD62P (%) = 5. 418, P < 0.01). Meanwhile, in the same state of illness, the A value for IgG ab2GPⅠ was positively correlated to the positive rates for PAC-I and CD62P. CONCLUSION:ab2GPⅠ level, platelet activation state and their relationship of them are closely correlated with the pathogenesis and development of UC.
引用
收藏
页码:771 / 775
页数:5
相关论文
共 17 条
[1]  
Etiopathogenesis of inflammatory bowel diseases[J]. Silvio Danese,Claudio Fiocchi.World Journal of Gastroenterology. 2006(30)
[2]  
Extraintestinal manifestations and complications in inflammatory bowel diseases[J]. Katja S Rothfuss,Eduard F Stange,Klaus R Herrlinger.World Journal of Gastroenterology. 2006(30)
[3]   Thrombosis and inflammatory bowel disease [J].
Irving, PM ;
Pasi, KJ ;
Rampton, DS .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (07) :617-628
[4]  
The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity[J] . Michal Harel,Anabel Aron-Maor,Yaniv Sherer,Miri Blank,Yehuda Shoenfeld.Immunobiology . 2005 (10)
[5]  
Research around &beta;2-glycoprotein I: A major target for antiphospholipid antibodies[J] . Tatsuya Atsumi,Olga Amengual,Shinsuke Yasuda,Eiji Matsuura,Takao Koike.Autoimmunity . 2005 (5)
[6]  
Antiphospholipid antibodies: update on detection, pathophysiology, and treatment[J] . Philip G de Groot,Ronald H.W.M Derksen.Current Opinion in Hematology . 2004 (3)
[7]   Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease [J].
Sonoda, K ;
Ikeda, S ;
Mizuta, Y ;
Miyahara, Y ;
Kohno, S .
JOURNAL OF GASTROENTEROLOGY, 2004, 39 (10) :948-954
[8]   Oral prednisolone metasulphobenzoate in the treatment of active ulcerative colitis [J].
Cameron, EAB ;
Binnie, JAH ;
Balan, K ;
Skerratt, SA ;
Swift, A ;
Solanki, C ;
Middleton, SJ .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (05) :535-537
[9]   Catastrophic antiphospholipid syndrome [J].
Ronald A. Asherson ;
Ricard Cervera .
Current Rheumatology Reports, 2003, 5 (5) :395-400
[10]   Hemostatic imbalance in active and quiescent ulcerative colitis [J].
van Bodegraven, AA ;
Schoorl, M ;
Baak, JPA ;
Linskens, RK ;
Bartels, PCM ;
Tuynman, HARE .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (02) :487-493